Company intelligence / Profile preview

Viscera Technologies

Ownership: Private
Development stage: Commercial

Overview

Quantico is a patented, smartphone-based lateral flow diagnostic platform that delivers quantitative, lab-quality results from blood or urine samples in minutes. It is designed for clinical, home, and remote use and aims to democratize access to high-quality diagnostics by eliminating the need for dedicated hardware. The system uses self-correcting algorithms to ensure accuracy regardless of environmental variables or device differences.

Therapeutic areas: Other
Modalities: DeviceDiagnostic platform (Lateral flow technology with smartphone integration)
Industry: Protein Biomarker Diagnostics

Partnerships

No specific partnerships disclosed; open to licensing/acquisition of their patented innovations

Beyond the preview

Go deeper on Viscera Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Viscera Technologies.

Explore the full profile